Join industry experts to learn more about Less Invasive Ventricular Enhancement™ (LIVE™) as a treatment option for reshaping the left ventricle to restore its pumping efficiency.
Professor of Cardiology & Cachexia Research, Applied Cachexia Research, Dept. of Cardiology, Charité, Campus Virchow-Klinikum, Berlin, Germany
2012-14 President of the Heart Failure Association (HFA) of the European Society of Cardiology
Overview of current heart failure therapies and guidelines.
Prognosis for patients and limitations of optimal medical therapy, cardiac anker_paragraph_5: resynchronization therapy, LVAD’s, and status of heart transplantation.
Cardiologist, Heart Failure Unit, I.R.C.C.S. Policlinico San Donato, Milan, Italy
Insights from the STICH trial: Patients that benefit from SVR.
Recent analysis of STICH showing Survival Benefit for SVR.
Professor of Cardiothoracic Surgery, Drexel University College of Medicine, wechsler_paragraph_2: Philadelphia, PA, USA
Technology review of the LIVE™ procedure and the Revivent™ Myocardial Anchoring System
Phase I human clinical data.
Forthcoming transcatheter approach.